CBS and Viacom have for over a year now been in on and off talks to once again merge according to a report from Fox Business. The two companies use to be one, but broke up into two companies in 2006, at the request of both boards. It is important to remember that both Viacom and CBS have the same controlling family: the Redstone family. Talks broke down last year, but since that happened the former CBS CEO has left and six board members have been replaced,
Now it looks like the Redstone family has cleared the way for a possible CBS and Viacom merger once again. Last year CPI reported that the Redstone family had dropped a condition to make Viacom’s current CEO the number 2 in control of the company after a merger. That reportedly cleared a major obstacle to the merger now with new CBS board members it once again looks like a merger may happen.
This push to make media companies like Viacom and CBS larger is not just about cord cutting. There is a growing number of content providers such as Netflix, Disney+, Hulu, and Amazon creating original programs enjoyed by cord cutters and cable subscribers alike. To help fight back from a shrinking viewership content, companies are hoping to grow their footprint through mergers like this one.
Full Content: Fox Business
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas